Thrombotic thombocytiopenic purpura, hemolytic-urenic syndromes, thrombotic microangiopathy;Purpuras thrombotiques thrombocytopeniques syndrome hemolytiques et uremiques micro-angiopathies thrombotiques

Hematologie

Volumn 4, Issue 1, 1998, Pages 75-87

  Rochant, Henri ^a   Gordjani, Nader ^b   Hénon, Philippe ^c   Rondeau, Eric ^d   Hermine, Olivier ^e  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY OF FREIBURG   (Germany)

^c CH de Mulhouse ^*  (France)

^d HÔPITAL TENON   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYTIC UREMIC SYNDROME; HUMAN; PATHOPHYSIOLOGY; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0031883689     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Moschowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries : an undescribed disease. Arch Int Med 1925 ; 36 : 89-91.
2. Gasser C, Gautier C, Steck A, Siebenmann RE, Oeschlin R. Hämolytisch-urämischen Syndrome : Bilaterale Nierenindennekrose bei akuten erworbenen hämolytishen Anämien Schweiz Med Wochschr 1955 ; 85 : 905-9.
3. Ruggenenti P, Lutz J, Remuzzi G. Pathogenesis and treatment of thrombotic microangiopathy. Kidney Int 1997; 51 (suppl. 58) : S97-101.
4. Kwaan HC, Ganguly P. Introduction : thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Semin Hematol 1997 ; 34: 81-2.
5. Hofmann SL. Southwestern internal medicine conference : Shiga like toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura. Am J Med Sci 1993 ; 306 : 398-406.
6. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 1995 ; 47 : 2-19.
7. Rondeau E, Peraldi MN. Escherichia coli and the hemolytic uremic syndrome. N Engl J Med 1996 ; 335 : 660-2.
8. Gordjani N, Sutor AH, Zimmerhockl LB, Brandis M. Haemolytic uremic syndromes. Semin Thromb Hemost 1997 ; 23 : 281-93.
9. Pickering LK, Obrig TG, Stapleton FB. Hemolytic-uremic syndrome and enterohemorragic Escherischia coli. Pediatr Infect Dis J 1994 ; 13 : 459-75.
10. Boyce TG, Swelow DL, Griffin PM. Escherischia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995 ; 333 : 364-8.
11. Keene WE, McAnulty JM, Hoesly FC, Williams LP Jr, Hedberg K, Oxman GL, Barrett TJ, Ppfaller MA, Fleming DW. A swimmingassociated outbreak of hemorragic colitis caused by Escherischia coli O157:H7 and Shigella sonnei. N Engl J Med 1994 ; 331 : 579-84
12. Fifzpatrick MM, Walters MD, Trompeter RS, Dillon MJ, Barratt TM. Atypical (non-diarrhea-associated) hemolytic uremic syndrome in childhood. J Pediatr 1993 ; 122 : 532-7.
13. Siegler RL, Pavia AT, Hansen FL, Christofferson RD, Cook JB. Atypical hemolytic-uremic syndrome : a comparison with post-diarrheal disease. J Pediatr 1996 ; 128 : 505-11.
14. Xu Y, Hagege J, Mougenot B, Sraer JD, Ronne E, Rondeau E. Different expressions of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int 1996 ; 50 : 2011-9.
15. Moake JL. Studies on the pathophysiology of thrombotic thrombocytopenic purpura. Semin Hématol 1997 ; 34 : 83-9.
16. Smith BR, Rinder HM. Interactions of platelets and endothelial cells with erythrocytes and leucocytes in thrombotic thrombocytopenic purpura. Semin Hematol 1997 ; 34 : 90-7.
17. Tarr PI. Escherichia coli O157:H7 : clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 1995 ; 20 : 1-10.
18. Gunzer F, Bohm H, Russmann H, Bitzan M, Aleksic S, Karch H. Molecular detection of sorbitol-fermenting Escherichia coli O157:H7 in patients with hemolytic-uremic syndrome. J Clin Microbiol 1992 ; 30 : 1807-10.
19. Arbus GS. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome. Kidney Int 1997 ; 51 (suppl. 58) : S91-6.
20. Armstrong GD, Rowe PC, Goodyer P, Orbrine E, Klassen TP, Wells G, McKenzie A, Lior H, Blanchard C, Auclaire F, Thompson B, Rafter DJ, McLaine PN. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic uremic syndrome. J Infect Dis 1995 ; 171 : 1042-5.
21. Proulx F, Turgeon JP, Delage G, Lafleur L, Chicoine L. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis, J Pediatr 1992 ; 121 : 299-303.
22. Loirat C, Sonsino E, Hinglais N, Jais JP, Landais P, Fermanian J. Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicenter randomized controlled trial. Pediatr Nephrol 1988 ; 2 : 279-85.
23. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med 1991 ; 325: 398-403.
24. Griffin M, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorragic E. coli and the associated hemolytic uremic syndrome. Epidemiol Rev 1991 ; 13 : 60-98.
25. Kensch GT, Acheson DWK. Thrombotic thrombocytopenic purpura associated with shiga toxins. Semin Hematol 1997 ; 34 : 106-16.
26. Bell BP, Goldoft M, Griffin PM, Davis MA, Gordon DC, Tarr PI, Bartleson CA, Lewis JH, Barrett TJ, Wells JG. A multistate outbreak of Escherischia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 1994 ; 272 : 1349-53.
27. Hymes HB, Karpatkin S. Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol 1997 ; 34 : 117-25.
28. Maslo C, Peraldi MN, Desenclos JC, Mougenot B, Cywiner Golenzer C, Chatelet FP, Jaconet C, Rondeau E, Rozenbaum W, Straer JD. Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997 ; 24 : 350-5.
29. Hertig A, Couprie R, Haymann JP, Mougenot B, Farres N, Peraldi MN, Rondeau E, Straer JD. Acute cortical necrosis in the acquired immuno-deficiency syndrome (AIDS). Nephrol Dial Transplant 1997 ; 12 : 585-7.
30. Gordon LI, Kwaan HC. Cancer and drugassociated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 1997 ; 34 : 140-7.
31. Hénon P. Traitement du purpura thrombotique thrombopénique. Résultats d'une étude clinique multi-centrique randomisée. Presse Med 1991 ; 20: 1761-7.
32. Ezra Y, Rose M, Eldor A. Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy : a clinical study of 16 pregnancies. Am J Hematol 1990 ; 51 : 1-6.
33. Pettiti AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994 : 495-504.
34. Dua A, Zeigler ZR, Shadduk RK, Naih R, Andrews DF 3rd, Agha M. Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy : a case series. J Clin Apheresis 1996 ; 11 : 176-84.
35. Bell WR. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome relapse : frequency, pathogenesis and meaning. Semin Hematol 1997 ; 34 : 134-9.
36. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA, and the Canadian apheresis study group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991 ; 325 : 393-7.
37. Kwaan HC, Soff GA. Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. N Engl J Med 1997 ; 34.: 159-66.